DA Davidson raised the firm’s price target on Synovus (SNV) to $63 from $60 and keeps a Buy rating on the shares. Synovus’ Q2 results represent a continuation of positive trends with regard to net interest income growth, net interest margin expansion, improving asset quality, and good expense control, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SNV:
- Synovus price target raised to $61 from $58 at Morgan Stanley
- Synovus Financial Outlook: Balancing Growth Potential with Cost Management Concerns
- Synovus price target raised to $65 from $55 at RBC Capital
- Synovus’s Strong Financial Performance and Strategic Positioning Drive Buy Rating
- Synovus upgraded to Outperform from Market Perform at Keefe Bruyette